Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?

QR Code

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?

Nuri Peker,1 Özge Çeliker Tosun2 1Department of Obstetrics and Gynecology, İstinye University Bahçeşehir Liv Hospital, Istanbul, Turkey; 2School of Physiotherapy, Dokuz Eylul University, Izmir, Turkey Objective: In this study, we investigated the relationship between...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Peker N, Çeliker Tosun Ö
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	menopause osteoporosis parity Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/197f56d52f0b4d27b4c60e5afad4d148
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
par: Luigi Gennari, et autres
Publié: (2010)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
par: Paula Rackoff
Publié: (2009)

Olive oil in the prevention and treatment of osteoporosis after artificial menopause
par: Liu HL, et autres
Publié: (2014)

Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial
par: Lai CL, et autres
Publié: (2013)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
par: Ma Z, et autres
Publié: (2016)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
par: Kawate H, et autres
Publié: (2011)

Muscular strength measurements indicate bone mineral density loss in postmenopausal women
par: Zhou Z, et autres
Publié: (2013)

Alendronate improves QOL of postmenopausal women with osteoporosis
par: Hisaya Kawate, et autres
Publié: (2010)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
par: Mederle OA, et autres
Publié: (2018)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
par: Baccaro LF, et autres
Publié: (2015)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
par: Tao Y, et autres
Publié: (2021)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
par: Fan Z, et autres
Publié: (2020)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
par: Fan T, et autres
Publié: (2013)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
par: Yu H, et autres
Publié: (2019)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
par: Philip Sambrook
Publié: (2007)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
par: Liu Z, et autres
Publié: (2020)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
par: Fujiwara S, et autres
Publié: (2014)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
par: Oliver Bock, et autres
Publié: (2008)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
par: John Sunyecz
Publié: (2008)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
par: Nagy EE, et autres
Publié: (2020)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
par: María J Moro-Álvarez, et autres
Publié: (2008)

Osteoporosis in men: epidemiology and treatment with denosumab
par: Sidlauskas KM, et autres
Publié: (2014)

Pharmacological treatment of osteoporosis in the oldest old
par: Vandenbroucke A, et autres
Publié: (2017)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
par: Tahir Masud, et autres
Publié: (2009)

Diagnosis of Presarcopenia Using Body Height and Arm Span for Postmenopausal Osteoporosis
par: Ono Y, et autres
Publié: (2020)

Role of zoledronic acid in the prevention and treatment of osteoporosis
par: Räkel A, et autres
Publié: (2011)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
par: Esteban Jódar-Gimeno
Publié: (2007)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
par: Ciubean AD, et autres
Publié: (2018)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
par: Piet Geusens
Publié: (2009)

Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
par: İlhan B, et autres
Publié: (2015)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
par: Victor G Vogel
Publié: (2008)

Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
par: Hettchen M, et autres
Publié: (2021)

Osteoporosis screening and risk management
par: Consuelo H Wilkins
Publié: (2007)

A review of minodronic acid hydrate for the treatment of osteoporosis
par: Tanishima S, et autres
Publié: (2013)

Management of osteoporosis in the aging male: Focus on zoledronic acid
par: Paul K Piper Jr, et autres
Publié: (2009)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
par: Claudia Gagnon, et autres
Publié: (2008)

Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
par: Chin KY, et autres
Publié: (2014)

Menopausal Symptoms and Associated Social and Environmental Factors in Midlife Chinese Women
par: Zhang L, et autres
Publié: (2020)

The influence of the serotonergic system on the personality and quality of life of postmenopausal women
par: Schneider-Matyka D, et autres
Publié: (2017)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)
par: Chen CH, et autres
Publié: (2020)